An early move by the president has raised questions about what direction his second-term policy on drug costs will take.
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...
More than 65 million Americans rely on the program for their health insurance, with a significant proportion of those being ...
The Claim "Donald Trump rescinded Biden's action to lower prescription drug costs for Americans on Medicare and Medicaid," ...
Declining enrollment, fewer plan offerings, and persistently higher premiums are raising concerns about the stability and ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...
President Donald Trump didn't wait long in his second term to begin shaking things up in Washington, D.C. In less than two ...
House Democrats want to know what the Trump administration plans to do after it rescinded a Biden-era executive order to ...
The Centers for Medicare and Medicaid Services (CMS) says about 8,247,000 people with Medicare Part D coverage use the ten drugs selected for price negotiation.
As of October 2022, Vascepa had coverage without restrictions for more than 90% of Medicare Part D enrollees, according to its manufacturer. According to Optum Perks, 30 capsules of Vascepa cost as ...